Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter

Sudhof, 2017, Molecular Neuroscience in the 21(st) Century: A Personal Perspective, Neuron, 96, 536, 10.1016/j.neuron.2017.10.005

Fantini, 2002, Lipid rafts: Structure, function and role in HIV, Alzheimer’s and prion diseases, Expert Rev. Mol. Med., 4, 1, 10.1017/S1462399402005392

Simons, 1997, Functional rafts in cell membranes, Nature, 387, 569, 10.1038/42408

Pike, 2006, Rafts defined: A report on the Keystone Symposium on Lipid Rafts and Cell Function, J. Lipid Res., 47, 1597, 10.1194/jlr.E600002-JLR200

Owen, 2012, Sub-resolution lipid domains exist in the plasma membrane and regulate protein diffusion and distribution, Nat. Commun., 3, 1256, 10.1038/ncomms2273

Hao, 2001, Cholesterol depletion induces large scale domain segregation in living cell membranes, Proc. Natl. Acad. Sci. USA, 98, 13072, 10.1073/pnas.231377398

Frisz, 2013, Direct chemical evidence for sphingolipid domains in the plasma membranes of fibroblasts, Proc. Natl. Acad. Sci. USA, 110, E613, 10.1073/pnas.1216585110

Frisz, 2013, Sphingolipid domains in the plasma membranes of fibroblasts are not enriched with cholesterol, J. Boil. Chem., 288, 16855, 10.1074/jbc.M113.473207

Fantini, J., and Yahi, N. (2015). Brain Lipids in Synaptic Function and Neurological Disease. Clues to Innovative Therapeutic Strategies for Brain Disorders, Elsevier. [1st ed.].

Borroni, 2016, The lipid habitats of neurotransmitter receptors in brain, Biochim. Biophys. Acta, 1858, 2662, 10.1016/j.bbamem.2016.07.005

Fantini, 2009, Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function, Biochim. Biophys. Acta, 1788, 2345, 10.1016/j.bbamem.2009.08.016

Allen, 2007, Lipid raft microdomains and neurotransmitter signaling, Nat. Rev. Neurosci., 8, 128, 10.1038/nrn2059

Devane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126/science.1470919

Bieberich, 2012, It’s a lipid’s world: Bioactive lipid metabolism and signaling in neural stem cell differentiation, Neurochem. Res., 37, 1208, 10.1007/s11064-011-0698-5

Lu, 2017, Cannabinoid signaling in health and disease, Can. J. Physiol. Pharmacol., 95, 311, 10.1139/cjpp-2016-0346

Sarne, 2005, Cannabinoids: Between neuroprotection and neurotoxicity, Current drug targets, CNS Neurol. Disord., 4, 677

Okamoto, 2007, Biosynthetic pathways of the endocannabinoid anandamide, Chem. Biodivers., 4, 1842, 10.1002/cbdv.200790155

Fride, 2002, Endocannabinoids in the central nervous system—An overview, Prostaglandins Leukot. Essent. Fatty Acids, 66, 221, 10.1054/plef.2001.0360

Brash, 2001, Arachidonic acid as a bioactive molecule, J. Clin. Investig., 107, 1339, 10.1172/JCI13210

Glickman, 1995, Nature of rate-limiting steps in the soybean lipoxygenase-1 reaction, Biochemistry, 34, 14077, 10.1021/bi00043a013

Bild, 1977, Double dioxygenation of arachidonic acid by soybean lipoxygenase-1, Biochem. Biophys. Res. Commun., 74, 949, 10.1016/0006-291X(77)91610-2

Reggio, 2000, Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase, Chem. Phys. Lipids, 108, 15, 10.1016/S0009-3084(00)00185-7

Mazzarino, 2017, Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data, Data Brief, 14, 163, 10.1016/j.dib.2017.07.024

Fantini, 2017, Hybrid In Silico/In Vitro Approaches for the Identification of Functional Cholesterol-Binding Domains in Membrane Proteins, Methods Mol. Boil., 1583, 7, 10.1007/978-1-4939-6875-6_2

Alger, 2004, Endocannabinoids: Getting the message across, Proc. Natl. Acad. Sci. USA, 101, 8512, 10.1073/pnas.0402935101

Kreitzer, 2002, Retrograde signaling by endocannabinoids, Curr. Opin. Neurobiol., 12, 324, 10.1016/S0959-4388(02)00328-8

Thakur, 2009, Surface chemistry of Alzheimer’s disease: A Langmuir monolayer approach, Colloids Surf. B Biointerfaces, 74, 436, 10.1016/j.colsurfb.2009.07.043

Di Scala, C., Yahi, N., Fantini, J., and Chahinian, H. (2017). Disruption of anandamide aggregates studied by surface pressure measurements, Unpublished data.

Castagnet, 2005, Fatty acid incorporation is decreased in astrocytes cultured from α-synuclein gene-ablated mice, J. Neurochem., 94, 839, 10.1111/j.1471-4159.2005.03247.x

Chivet, 2012, Emerging role of neuronal exosomes in the central nervous system, Front. Physiol., 3, 145, 10.3389/fphys.2012.00145

Ricci, 2016, DMSO-induced perturbation of thermotropic properties of cholesterol-containing DPPC liposomes, Biochim. Biophys. Acta, 1858, 3024, 10.1016/j.bbamem.2016.09.012

Gurtovenko, 2007, Modulating the structure and properties of cell membranes: The molecular mechanism of action of dimethyl sulfoxide, J. Phys. Chem. B, 111, 10453, 10.1021/jp073113e

Gustavsson, 1990, Brain lipid changes after ethanol exposure, Upsala J. Med. Sci. Suppl., 48, 245

Di Pasquale, E., Chahinian, H., Sanchez, P., and Fantini, J. (2009). The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent. PLoS ONE, 4.

Howlett, 2017, CB1 and CB2 Receptor Pharmacology, Adv. Pharmacol., 80, 169, 10.1016/bs.apha.2017.03.007

Hurst, 2002, Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor, J. Med. Chem., 45, 3649, 10.1021/jm0200761

Tian, 2005, The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer, J. Boil. Chem., 280, 29788, 10.1074/jbc.M502925200

Howlett, 2011, Endocannabinoid tone versus constitutive activity of cannabinoid receptors, Br. J. Pharmacol., 163, 1329, 10.1111/j.1476-5381.2011.01364.x

Fowler, 2013, Transport of endocannabinoids across the plasma membrane and within the cell, FEBS J., 280, 1895, 10.1111/febs.12212

Fegley, 2004, Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172, Proc. Natl. Acad. Sci. USA, 101, 8756, 10.1073/pnas.0400997101

Maccarrone, 2017, Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years, Front. Mol. Neurosci., 10, 166, 10.3389/fnmol.2017.00166

Glaser, 2005, Anandamide transport: A critical review, Life Sci., 77, 1584, 10.1016/j.lfs.2005.05.007

Hermann, 2006, 2-Arachidonoylglycerol (2-AG) membrane transport: History and outlook, AAPS J., 8, E409, 10.1007/BF02854913

Aureli, 2015, Lipid membrane domains in the brain, Biochim. Biophys. Acta, 1851, 1006, 10.1016/j.bbalip.2015.02.001

Marquardt, 2016, Cholesterol’s location in lipid bilayers, Chem. Phys. Lipids, 199, 17, 10.1016/j.chemphyslip.2016.04.001

Schmidt, 2017, Liquid Disordered-Liquid Ordered Phase Coexistence in Lipid/Cholesterol Mixtures: A Deuterium 2D NMR Exchange Study, Langmuir, 33, 1881, 10.1021/acs.langmuir.6b02834

Thakur, 2011, Surface chemistry of lipid raft and amyloid Aβ (1–40) Langmuir monolayer, Colloids Surf. B Biointerfaces, 87, 369, 10.1016/j.colsurfb.2011.05.047

Hammache, 2000, Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions, Methods Enzymol., 312, 495, 10.1016/S0076-6879(00)12934-9

Chahinian, 2014, Interaction of Alzheimer’s β-amyloid peptides with cholesterol: Mechanistic insights into amyloid pore formation, Biochemistry, 53, 4489, 10.1021/bi500373k

Mazzarino, 2017, Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells, Chem. Phys. Lipids, 205, 11, 10.1016/j.chemphyslip.2017.04.001

Lonnfors, 2013, Cholesteryl phosphocholine—A study on its interactions with ceramides and other membrane lipids, Langmuir, 29, 2319, 10.1021/la3051324

Metcalf, 2012, Mixing properties of sphingomyelin ceramide bilayers: A simulation study, J. Phys. Chem. B., 116, 4500, 10.1021/jp212325e

Bari, 2005, Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis, J. Boil. Chem., 280, 12212, 10.1074/jbc.M411642200

Sarnataro, 2005, Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells, FEBS Lett., 579, 6343, 10.1016/j.febslet.2005.10.016

Rukmini, 2001, Cholesterol organization in membranes at low concentrations: Effects of curvature stress and membrane thickness, Biophys. J., 81, 2122, 10.1016/S0006-3495(01)75860-2

Mukherjee, 1996, Membrane organization at low cholesterol concentrations: A study using 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled cholesterol, Biochemistry, 35, 1311, 10.1021/bi951953q

Bennett, 2012, Molecular simulation of rapid translocation of cholesterol, diacylglycerol, and ceramide in model raft and nonraft membranes, J. Lipid Res., 53, 421, 10.1194/jlr.M022491

Fantini, 2016, A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes, Sci. Rep., 6, 21907, 10.1038/srep21907

Kaczocha, 2009, Identification of intracellular carriers for the endocannabinoid anandamide, Proc. Natl. Acad. Sci. USA, 106, 6375, 10.1073/pnas.0901515106

Fezza, 2008, Fatty acid amide hydrolase: A gate-keeper of the endocannabinoid system, Sub-Cell. Biochem., 49, 101, 10.1007/978-1-4020-8831-5_4

Cravatt, 1996, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, 384, 83, 10.1038/384083a0

Reggio, 2010, Endocannabinoid binding to the cannabinoid receptors: What is known and what remains unknown, Curr. Med. Chem., 17, 1468, 10.2174/092986710790980005

Picone, 2005, (−)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a high-affinity electrophilic ligand, interacts covalently with a cysteine in helix six and activates the CB1 cannabinoid receptor, Mol. Pharmacol., 68, 1623, 10.1124/mol.105.014407

Gimpl, 2016, Interaction of G protein coupled receptors and cholesterol, Chem. Phys. Lipids, 199, 61, 10.1016/j.chemphyslip.2016.04.006

Paila, 2009, Are specific nonannular cholesterol binding sites present in G-protein coupled receptors?, Biochim. Biophys. Acta, 1788, 295, 10.1016/j.bbamem.2008.11.020

Gimpl, 1997, Cholesterol as modulator of receptor function, Biochemistry, 36, 10959, 10.1021/bi963138w

Paila, 2010, Membrane cholesterol in the function and organization of G-protein coupled receptors, Sub-Cell. Biochem., 51, 439, 10.1007/978-90-481-8622-8_16

Ma, 2017, The cubicon method for concentrating membrane proteins in the cubic mesophase, Nat. Protoc., 12, 1745, 10.1038/nprot.2017.057

Grisshammer, 2017, New approaches towards the understanding of integral membrane proteins: A structural perspective on G protein-coupled receptors, Protein Sci., 26, 1493, 10.1002/pro.3200

Caffrey, 2003, Membrane protein crystallization, J. Struct. Boil., 142, 108, 10.1016/S1047-8477(03)00043-1

Yin, 2014, GPCR crystallization using lipidic cubic phase technique, Curr. Pharm. Biotechnol., 15, 971, 10.2174/1389201015666140922110325

Hanson, 2008, A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor, Structure, 16, 897, 10.1016/j.str.2008.05.001

Baier, 2017, Relevance of CARC and CRAC Cholesterol-Recognition Motifs in the Nicotinic Acetylcholine Receptor and Other Membrane-Bound Receptors, Curr. Top. Membr., 80, 3, 10.1016/bs.ctm.2017.05.001

Jamin, 2005, Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor, Mol. Endocrinol., 19, 588, 10.1210/me.2004-0308

Baier, 2011, Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor, Sci. Rep., 1, 69, 10.1038/srep00069

Fantini, 2016, Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains, Chem. Phys. Lipids, 199, 52, 10.1016/j.chemphyslip.2016.02.009

Hua, 2017, Crystal structures of agonist-bound human cannabinoid receptor CB1, Nature, 547, 468, 10.1038/nature23272

Gater, 2014, Two classes of cholesterol binding sites for the β2AR revealed by thermostability and NMR, Biophys. J., 107, 2305, 10.1016/j.bpj.2014.10.011

Manna, M., Niemela, M., Tynkkynen, J., and Javanainen, M. (2016). Mechanism of allosteric regulation of β2-adrenergic receptor by cholesterol. eLife, 5.

Hua, 2016, Crystal Structure of the Human Cannabinoid Receptor CB1, Cell, 167, 750, 10.1016/j.cell.2016.10.004

Sabatucci, 2018, In silico mapping of allosteric ligand binding sites in type-1 cannabinoid receptor, Biotechnol. Appl. Biochem., 65, 21, 10.1002/bab.1589

Park, 2008, Crystal structure of the ligand-free G-protein-coupled receptor opsin, Nature, 454, 183, 10.1038/nature07063

Hildebrand, P.W., Scheerer, P., Park, J.H., Choe, H.W., Piechnick, R., Ernst, O.P., Hofmann, K.P., and Heck, M. (2009). A ligand channel through the G protein coupled receptor opsin. PLoS ONE, 4.

Ledeen, 2008, Nuclear sphingolipids: Metabolism and signaling, J. Lipid Res., 49, 1176, 10.1194/jlr.R800009-JLR200

Parolaro, 2002, Endocannabinoids in the immune system and cancer, Prostaglandins Leukot. Essent. Fatty Acids, 66, 319, 10.1054/plef.2001.0355

Biswas, 2003, Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis, Hepatology, 38, 1167, 10.1053/jhep.2003.50459

Dainese, 2007, Modulation of the endocannabinoid system by lipid rafts, Curr. Med. Chem., 14, 2702, 10.2174/092986707782023235

Yang, 2010, Anandamide induces cell death through lipid rafts in hepatic stellate cells, J. Gastroenterol. Hepatol., 25, 991, 10.1111/j.1440-1746.2009.06122.x

McFarland, 2005, Lipid rafts: A nexus for endocannabinoid signaling?, Life Sci., 77, 1640, 10.1016/j.lfs.2005.05.010

Sarker, 2003, Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: Possible involvement of lipid rafts, Cell. Mol. Life Sci., 60, 1200, 10.1007/s00018-003-3055-2

Kaczocha, 2012, Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion, ACS Chem. Neurosci., 3, 364, 10.1021/cn300001w

Dainese, 2014, Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH, Biochem. J., 457, 463, 10.1042/BJ20130960

Sanson, 2014, Crystallographic study of FABP5 as an intracellular endocannabinoid transporter, Acta Crystallogr. Sect. D Biol. Crystallogr., 70, 290, 10.1107/S1399004713026795

Hannun, 2000, Ceramide in the eukaryotic stress response, Trends Cell Boil., 10, 73, 10.1016/S0962-8924(99)01694-3

Sarda, 1958, Actions of pancreatic lipase on esters in emulsions, Biochim. Biophys. Acta, 30, 513, 10.1016/0006-3002(58)90097-0

Chahinian, 2010, Non-lipolytic and lipolytic sequence-related carboxylesterases: A comparative study of the structure-function relationships of rabbit liver esterase 1 and bovine pancreatic bile-salt-activated lipase, Biochim. Biophys. Acta, 1801, 1195, 10.1016/j.bbalip.2010.07.002

Airola, 2015, Structural Basis for Ceramide Recognition and Hydrolysis by Human Neutral Ceramidase, Structure, 23, 1482, 10.1016/j.str.2015.06.013

Ira, and Johnston, L.J. (2008). Sphingomyelinase generation of ceramide promotes clustering of nanoscale domains in supported bilayer membranes. Biochim. Biophys. Acta, 1778, 185–197.

Somerharju, 2009, The superlattice model of lateral organization of membranes and its implications on membrane lipid homeostasis, Biochim. Biophys. Acta, 1788, 12, 10.1016/j.bbamem.2008.10.004

Huang, 1996, Ceramide induces structural defects into phosphatidylcholine bilayers and activates phospholipase A2, Biochem. Biophys. Res. Commun., 220, 834, 10.1006/bbrc.1996.0490

Trajkovic, 2008, Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, 319, 1244, 10.1126/science.1153124

Zha, 1998, Sphingomyelinase treatment induces ATP-independent endocytosis, J. Cell Boil., 140, 39, 10.1083/jcb.140.1.39

Movsesyan, 2004, Anandamide-induced cell death in primary neuronal cultures: Role of calpain and caspase pathways, Cell Death Differ., 11, 1121, 10.1038/sj.cdd.4401442

Giuffrida, 2001, Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology, J. Pharmacol. Exp. Ther., 298, 7

Di Scala, C., Yahi, N., Fantini, J., and Chahinian, H. (2017). Effect of sphingomyelinase on the mitochondrial toxicity of anandamide in cultured neural cells, Unpublished data.

Smart, 2000, The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1), Br. J. Pharmacol., 129, 227, 10.1038/sj.bjp.0703050

Ryberg, 2007, The orphan receptor GPR55 is a novel cannabinoid receptor, Br. J. Pharmacol., 152, 1092, 10.1038/sj.bjp.0707460

Di Scala, C., Yahi, N., Fantini, J., and Chahinian, H. (2017). Real-time PCR determinations of CB1 and prominin mRNAs expression profile in anandamide-treated cells, Unpublished data.

De, 2017, Ligresti, Actions and Regulation of Ionotropic Cannabinoid Receptors, Adv. Pharmacol., 80, 249, 10.1016/bs.apha.2017.04.001

Shimasue, 1996, Effects of anandamide and arachidonic acid on specific binding of (+)-PN200-110, diltiazem and (−)-desmethoxyverapamil to L-type Ca2+ channel, Eur. J. Pharmacol., 296, 347, 10.1016/0014-2999(95)00826-8

Barann, 2002, Direct inhibition by cannabinoids of human 5-HT3A receptors: Probable involvement of an allosteric modulatory site, Br. J. Pharmacol., 137, 589, 10.1038/sj.bjp.0704829

Liu, 2006, TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors, Eur. J. Neurosci., 24, 1, 10.1111/j.1460-9568.2006.04889.x

Nothdurfter, 2010, Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants, Neuropsychopharmacology, 35, 1510, 10.1038/npp.2010.20

Tsujikawa, 2008, Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes, American journal of physiology, Heart Circ. Physiol., 294, H285, 10.1152/ajpheart.00824.2007

Chik, 2004, Ceramide inhibits L-type calcium channel currents in GH3 cells, Mol. Cell. Endocrinol., 218, 175, 10.1016/j.mce.2003.10.048

Velasco, 2005, Cannabinoids and ceramide: Two lipids acting hand-by-hand, Life Sci., 77, 1723, 10.1016/j.lfs.2005.05.015

Truman, 2014, Evolving concepts in cancer therapy through targeting sphingolipid metabolism, Biochim. Biophys. Acta, 1841, 1174, 10.1016/j.bbalip.2013.12.013

Gustafsson, 2009, Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism, Mol. Cancer Res., 7, 1086, 10.1158/1541-7786.MCR-08-0361